Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

2.

Pressing the Sleep button could have a positive impact on cognition.

3.

These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?

4.

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

5.

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot